M. Kidd and I. M. Modlin, A Century of Helicobacter pylori. Paradigms Lost-Paradigms Regained, Digesion, vol.59, pp.1-15, 1998.

B. J. Marshall and J. R. Warren, Unideniied curved bacilli in the stomach of paients with gastriis and pepic ulceraion, Lancet, vol.16, issue.8390, pp.1311-1316, 1984.

C. Burucoa, F. Denis, V. Catoir, C. Marin, M. C. Ploy et al., Bactériologie Médicale Techniques usuelles. 3e édiion, pp.389-401, 2016.

F. Mégraud, Helicobacter pylori: caractères bactériologiques, méthodes diagnosiques et sensibilité aux anibioiques. La presse médicale, vol.37, pp.507-512, 2008.

K. Yokota, M. Kita, H. Okada, O. Matsushita, and K. Oguma,

N. Rinsho, , vol.71, pp.1374-1383, 2013.

D. Moussata, D. Korwin, and J. D. , Gastrites chroniques. EMC-Gastro-entérologie, vol.10, issue.1, pp.1-12, 2014.

J. F. Tomb, O. White, A. R. Kerlavage, R. A. Clayton, G. G. Suton et al., The complete genome sequence of the gastric pathogen Helicobacter pylori, Nature, vol.388, issue.6642, pp.539-586, 1997.

J. D. De-korwin and P. Lehours, Helicobacter pylori: noions fondamentales, épidémiologie, méthodes diagnosiques. EMC-Gastro-entérologie, pp.1-16, 2010.

N. Salama, K. Guillemin, T. K. Mcdaniel, G. Sherlock, L. Tompkins et al., A whole-genome microarray reveals geneic diversity among Helicobacter pylori strains, Proc Natl Acad Sci, vol.97, issue.26, pp.14668-73, 2000.

J. Hooi, W. Y. Lai, W. K. Ng, M. Suen, F. E. Underwood et al., Global Prevalence of Helicobacter pylori Infecion: Systemaic Review and Meta-Analysis

, Gastroenterology, vol.153, issue.2, pp.420-429, 2017.

N. Broutet, A. M. Sarasqueta, F. Cantet, D. Lethuaire, and F. Mégraud, Is there a link between the variaion in gastric cancer mortality and diferences in Helicobacter pylori prevalence in diferent regions of France, Gastroentérologie Clinique et Biologique, vol.23, p.754, 1999.

N. Broutet, Épidémiologie de l'infecion à Helicobacter pylori. Revue Française des Laboratoires, pp.25-31, 1999.

R. J. Hopkins, L. S. Girardi, and E. A. Turney, Relaionship between Helicobacter pylori eradicaion and reduced duodenal and gastric ulcer recurrence: a review, Gastroenterology, 1996.

A. C. Ford, K. S. Gurusamy, B. Delaney, D. Forman, and P. Moayyedi, Eradicaion therapy for pepic ulcer disease in Helicobacter pylori-posiive people. Cochrane Database Syst Rev, 2016.

, Internaional Agency for research on Cancer. Global cancer observatory

, /today/online-analysis-muli-bars

R. Lambert, Épidémiologie du cancer gastrique dans le monde. Cancéro dig, vol.2, pp.31-37, 2010.

, World Health Organizaion. Schistosomes, liver lukes and helicobacter pylori, p.61, 1994.

D. M. Parkin, The global health burden of infecion-associated cancers in the year 2002, Int J Cancer, vol.118, issue.12, pp.3030-3074, 2006.

F. Mégraud, Quand et comment s'infecte t-on par Helicobacter pylori. gastroen clin bioL, vol.27, pp.374-383, 2003.

L. H. Eusebi, R. M. Zagari, and F. Bazzoli, Epidemiology of Helicobacter pylori infecion

, Helicobacter, issue.1, pp.1-5, 2014.

M. Kitagawa, M. Natori, M. Katoh, K. Sugimoto, H. Omi et al., Maternal transmission of Helicobacter pylori in the perinatal period, J Obstet Gynaecol Res, 2001.

S. Mamishi, H. Eshaghi, S. Mahmoudi, A. Bahador, . Hosseinpour et al., Intrafamilial transmission of Helicobacter pylori: genotyping of faecal samples, Br J Biomed Sci, vol.73, issue.1, pp.38-43, 2016.

B. Dolanab, L. Burkit-grayab, and S. Shovelina,

M. , The use of stool specimens reveals Helicobacter pylori strain diversity in a cohort of adolescents and their family members in a developed country, Int J Med Microbiol, 2018.

L. Moreno-mesonero, Y. Moreno, J. L. Alonso, and M. A. Ferrús, Detecion of viable Helicobacter pylori inside free-living amoebae in wastewater and drinking water samples from Eastern Spain, Environ Microbiol, vol.19, issue.10, pp.4103-4112, 2017.

R. K. Aziz, M. M. Khalifa, and R. R. Sharaf, Contaminated water as a source of Helicobacter pylori infecion: A review, J Adv Res, vol.6, issue.4, pp.539-547, 2015.

I. Tirodimos, M. Bobos, E. Kazakos, A. B. Haidich, and T. Dardavessis,

M. , Molecular detecion of Helicobacter pylori in a large Mediterranean river, by direct viable count luorescent in situ hybridizaion (DVC-FISH), J Water Health, vol.12, issue.4, pp.868-73, 2014.

P. Saniago, Y. Moreno, and M. A. Ferrús, Ideniicaion of Viable Helicobacter pylori in Drinking Water Supplies by Cultural and Molecular Techniques, Helicobacter, vol.20, issue.4, pp.252-261, 2015.

B. Hemmainezhad, H. Momtaz, and E. Rahimi, VacA, cagA, iceA and oipA genotypes status and animicrobial resistance properies of Helicobacter pylori isolated from various types of ready to eat foods, Ann Clin Microbiol Animicrob, vol.15, issue.2, 2016.

E. L. Walton, Helicobacter pylori's road to colonizaion, Biomed J, vol.39, issue.1, pp.1-4, 2016.

E. Aihara, C. Closson, A. L. Mathis, M. A. Schumacher, A. C. Engevik et al., Moility and Chemotaxis Mediate the Preferenial Colonizaion of Gastric Injury Sites by Helicobacter pylori. PLOS pathogens, vol.10, 2014.
DOI : 10.1371/journal.ppat.1004275

URL : https://doi.org/10.1371/journal.ppat.1004275

J. Y. Huang, E. G. Sweeney, M. Sigal, H. C. Zhang, S. J. Remington et al.,

, Chemodetecion and Destrucion of Host Urea Allows Helicobacter pylori to Locate the Epithelium. Cell Host Microbe, vol.18, pp.147-56, 2015.

Y. Huang, Q. L. Wang, D. D. Cheng, W. T. Xu, and N. H. Lu, Adhesion and Invasion of Gastric Mucosa Epithelial Cells by Helicobacter pylori, Front Cell Infect Microbiol, vol.6, p.159, 2016.

D. Lamarque, T. Van-nhieu, J. Breban, and M. , Quelles sont les modiicaions gastriques induites par l'infecion aiguë et chronique par Helicobacter pylori, Gastroen clin et bioL, vol.27, pp.391-400, 2003.

A. M. Costa, M. Leite, R. Seruca, and C. Figueiredo, Adherens juncions as targets of microorganisms: a focus on Helicobacter pylori. FEBS Let, vol.587, pp.259-65, 2013.

Y. Yamaoka, O. Ojo, S. Fujimoto, S. Odenbreit, R. Haas et al., Helicobacter pylori outer membrane proteins and gastroduodenal disease, Gut, vol.55, issue.6, pp.775-81, 2006.

Y. Matsuo, Y. Kido, and Y. Yamaoka, Helicobacter pylori Outer Membrane Protein-Related Pathogenesis. Toxins (Basel), vol.9, p.101, 2017.

Y. Yamaoka and D. Y. Graham, Helicobacter pylori virulence and cancer pathogenesis, Future Oncol, vol.10, issue.8, pp.1487-1500, 2014.

C. Varon and F. Mégraud, Infecion à Helicobacter pylori et cancer gastrique. Revue francophone des laboratoires, vol.13, pp.67-76, 2013.

N. Bouarioua, M. Merrouche, D. Pospai, and M. Mignon, Physiopathologie de la maladie ulcéreuse gastroduodénale à l'ère d'« Helicobacter pylori

J. C. Delchier, Histoire naturelle de la carcinogenèse gastrique liée à Helicobacter pylori, Rev Prat, vol.64, issue.2, pp.195-203, 2014.

B. Peleteiro and N. Lunet, Role of Geneic and Environmental Risk Factors in Gastric Carcinogenesis Pathway, Tonino , editor. Gastriis and Gastric Cancer-New Insights in Gastroprotecion, pp.197-216, 2011.

C. Besson, L'infecion a Helicobacter pylori : un modèle pour comprendre les mécanismes de lymphomes. La Revue du Praicien, vol.1, pp.39-40, 2010.

A. Fourmestraux, Mise au point. Les lymphomes gastriques du MALT

, Médecine Interne, pp.573-581, 1925.

P. Moayyedi, S. Soo, J. Deeks, B. Delaney, A. Harris et al., Eradicaion of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev, 2006.

B. Zhao, J. Zhao, W. F. Cheng, W. J. Shi, W. Liu et al., Eicacy of Helicobacter pylori eradicaion therapy on funcional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up, J Clin Gastroenterol, vol.48, issue.3, pp.241-248, 2014.

E. El-omar, I. Penman, C. A. Dorrian, J. E. Ardill, and K. E. Mccoll, Eradicaing Helicobacter pylori infecion lowers gastrin mediated acid secreion by two thirds in paients with duodenal ulcer, Gut, vol.34, issue.8, pp.1060-1065, 1993.

S. F. Moss and J. Calam, Acid secreion and sensiivity to gastrin in paients with duodenal ulcer: efect of eradicaion of Helicobacter pylori, Gut, vol.34, issue.7, pp.888-92, 1993.

P. Malfertheiner and U. Peitz, The interplay between Helicobacter pylori, gastro-oesophageal relux disease, and intesinal metaplasia, Gut, vol.54, issue.1, pp.13-20, 2005.

F. Pace and G. Bianchi-porro, Gastro-oesophageal relux and Helicobacter pylori, Ital J Gastroenterol Hepatol, vol.30, issue.3, pp.289-93, 1998.

A. S. Raghunath, A. P. Hungin, D. Woof, and S. Childs, Systemaic review: the efect of Helicobacter pylori and its eradicaion on gastro-oesophageal relux disease in paients with duodenal ulcers or relux oesophagiis, Aliment Pharmacol Ther, vol.20, issue.7, pp.733-777, 2004.

J. Tan, Y. Wang, X. Sun, W. Cui, J. Ge et al., The efect of Helicobacter pylori eradicaion therapy on the development of gastroesophageal relux disease, Am J Med Sci, 2015.

M. Franchini, M. Cruciani, C. Mengoli, G. Pizzolo, and D. Veneri, Efect of Helicobacter pylori eradicaion on platelet count in idiopathic thrombocytopenic purpura: a systemaic review and meta-analysis, J Animicrob Chemother, vol.60, issue.2, pp.237-283, 2007.

J. D. De-korwin, Existe-t-il des manifestaions extradigesives de l'infecion à Helicobacter pylori?. La Presse Médicale, vol.37, pp.525-534, 2008.

G. H. Frydman, N. Davis, P. L. Beck, and J. G. Fox, Helicobacter pylori Eradicaion in Paients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography, Helicobacter, vol.20, issue.4, pp.239-51, 2015.

C. Dufour, M. Brisigoi, G. Fabrei, P. Luxardo, P. G. Mori et al., Helicobacter pylori gastric infecion and sideropenic refractory anemia, J Pediatr Gastroenterol Nutr, 1993.

S. Nahon, Anémie ferriprive inexpliquée et gastrite chronique à Helicobacter pylori. Immunoanalyse and biologie spécialisée, vol.24, pp.267-271, 2009.

E. Nour, A. Sabbek, S. Jardak, B. Slama, H. Jaziri et al., Quel est le rôle de l'infecion par l'Hélicobacter pylori dans l'anémie ferriprive ?. La Revue de Médecine Interne, p.38, 2017.

D. G. Federman, R. S. Kirsner, J. P. Moriarty, and J. Concato, The efect of anibioic therapy for paients infected with Helicobacter pylori who have chronic uricaria, J Am Acad Dermatol, vol.49, issue.5, pp.861-865, 2003.

Z. Kutlubay, T. Zara, B. Engin, S. Serdaro?lu, Y. Tüzün et al., Helicobacter pylori infecion and skin disorders, Hong Kong Med J, vol.20, issue.4, pp.317-341, 2014.

F. Franceschi, A. Tortora, G. Gasbarrini, and A. Gasbarrini, Helicobacter pylori and extragastric diseases, Helicobacter, issue.1, pp.52-60, 2014.

H. Autorité-de-santé, Perinence des soins-Diagnosic de l'infecion par Helicobacter pylori chez l'adulte. Mai, 2017.

P. Moayyedi, S. Soo, J. Deeks, B. Delaney, A. Harris et al., Eradicaion of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev, 2006.

R. Stasi, A. Sarpatwari, J. B. Segal, J. Osborn, M. L. Evangelista et al., Efects of eradicaion of Helicobacter pylori infecion in paients with immune thrombocytopenic purpura: a systemaic review, Blood, vol.113, issue.6, pp.1231-1271, 2009.

J. D. De-korwin, Nouvelles recommandaions pour le diagnosic et le traitement de l'infecion à Helicobacter pylori. Presse Médicale, vol.42, pp.309-326, 20131.

P. Malfertheiner, F. Megraud, O. 'morain, C. A. Gisbert, J. P. Kuipers et al.,

, Management of Helicobacter pylori infecion-the Maastricht V/Florence Consensus Report, Gut, vol.66, issue.1, pp.6-30, 20171.

J. D. De-korwin, N. Kalach, J. Raymond, and C. Burucoa, Prise en charge diagnosique et thérapeuique en cas d'infecion à Helicobacter pylori. EMC-Gastro-entérologie, vol.9, pp.1-11, 201418.

H. Autorité-de-santé, Dépistage de l'infecion à Helicobacter pylori-Perinence et populaions concernées, 2010.

J. C. Delchier, A. Courillon-mallet, and D. Lamarque, Conseil de praique-Infecion à

Y. Ouharzoune, Place de la culture en 2016 dans le diagnosic des infecions à Helicobacter pylori. Opion Bio, vol.28, pp.13-14, 2017.

T. U. Kosunen, K. Seppäla, S. Sarna, and P. Sipponen, Diagnosic value of decreasing IgG, IgA, and IgM anibody itres ater eradicaion of Helicobacter pylori. The Lancet, Avr, vol.11, issue.8798, pp.893-898, 1992.

, Premier rapport de l'OMS sur la résistance aux anibioiques: une menace grave d'ampleur mondiale, 2014.

F. Megraud, Surveillance de la résistance de Helicobacter pylori aux anibioiques, Surveillance naionale des maladies infecieuses, 1998.

E. Rouault, A. Buissonnière, L. Labadi, A. Blumrich, H. Lamouliate et al., A Five Year Follow-up of Helicobacter pylori resistance to Fluoroquinolones in Bordeaux, Helicobacter, vol.11, pp.325-341, 2006.

J. Raymond, D. Lamarque, N. Kalach, S. Chaussade, and C. Burucoa, High level of animicrobial resistance in French Helicobacter pylori isolates, Helicobacter, vol.15, issue.1, pp.21-28, 2010.

F. Megraud, S. Coenen, and A. Versporten, Helicobacter pylori resistance to anibioics in Europe and its relaionship to anibioic consumpion, Gut, vol.62, pp.34-42, 2013.

J. C. Delchier, Traitement de l'infecion à Helicobacter pylori par trithérapie classique versus thérapie guidée par un test moléculaire de détecion des résistances aux anibioiques: résultats de l'étude Helicosic. Mars, Journée francophone d'Hépato-gastroentérologie et d'Oncologie Digesive, 2012.

P. Lehours, Epidémiologie de la sensibilité aux anibioiques de

/. Helicobacter and . Campylobacter, 15es Journées Naionales d'Infeciologie mercredi 11 au vendredi 13 juin, 2014.

A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède, P. Lehours et al., Helicobacter pylori resistance to anibioics in 2014 in France detected by phenotypic and genotypic methods

, Clin Microbiol Infect, vol.22, issue.8, pp.715-723, 2016.

, Quels traitements, 2018.

H. Autorité-de-santé, Perinence des soins-Traitement de l'infecion par Helicobacter pylori chez l'adulte. Mai, 2017.

E. Metchnikof, Topics hygiene, longevity. In: The prolongaion of life: opimisic studies, 1908.

, « Probioiques, prébioiques, symbioiques : déiniions ». Cahiers de Nutriion et de Diétéique. avril 2007, vol.42, p.7

K. C. Anukam and G. Reid, Probioics: 100 years (1907-2007) ater Elie Metchnikof's Observaion, 2007.

D. M. Lilly and R. H. Sillwell, Probioics: growth-promoing factors produced by microorganisms, Science, vol.147, issue.3659, pp.747-755, 1965.

J. C. Rambaud, J. P. Buts, G. Corthier, and B. Flourié, Flore microbienne intesinale: physiologie et pathologie digesives, John Libbey Eurotext, 2004.

, Consultaion mixte d'experts FAO/OMS sur l'évaluaion des propriétés sanitaires et nutriionelles des probioiques dans les aliments, y compris le lait en poudre contenant des bactéries laciques vivantes, 2001.

, World Gastroenterology Organisaion. Global Guidelines. Probioiques et Prébioiques. Octobre, 2011.

, Code de la santé publique. Aricle L5151-1. Legifrance

, Avis de l'agence naionale de sécurité sanitaire de l'alimentaion de l'environnement et du travail relaif à l'évaluaion de la sécurité d'emploi de la souche Lactobacillus reuteri mise en oeuvre en tant qu'ingrédient dans une préparaion pour nourrissons. Agense naionale de sécurité sanitaire de l'alimentaion de l'environnement et du travail, 2011.

. Europe and . Règlement,

, décembre 2006 concernant les allégaions nutriionnelles et de santé portant sur les denrées alimentaires

J. L. Bresson, B. Burlingame, T. Dean, S. Fairweather-tait, M. Heinonen et al.,

, Lactobacillus plantarum 299v and an increase of non-haem iron absorpion: evaluaion of a health claim pursuant to Aricle 13(5) of Regulaion (EC) No 1924/2006. EFSA Panel on Dieteic Products, Nutriion and Allergies, vol.14, 2016.

, Direcive 2002/46/CE. Parlement Européen

. Dgccrf-teleicare, Télé-procédure de déclaraion des compléments alimentaires, 2016.

, World Gastroenterology Organisaion. Global Guidelines. Probioiques et Prébioiques. Février, 2017.

P. Marteau and . Probioiques, , pp.291-303, 2017.

A. Aguilar-galvez, R. Dubois-dauphin, J. Destain, D. Campos, and P. Thonart, Les enterocoques: avantages et inconvénients en biotechnologie (synthèse bibliographique), Biotecnol. Agron. Soc. Environ, vol.16, issue.1, pp.67-76, 2012.

. Suisse, Compendium des médicaments, 2018.

B. Flourié and S. Nancey, Propriétés foncionnelles des probioiques. Cahier de nutriion et de diétéique, vol.42, pp.38-44, 2007.

P. Pochart, P. Marteau, Y. Bouhnik, I. Goderel, P. Bourlioux et al., Survival of biidobacteria ingested via fermented milk during their passage through the human small intesine: an in vivo study using intesinal perfusion, Am J Clin Nutr, vol.55, issue.1, pp.78-80, 1992.

C. N. Jacobsen, R. Nielsen, V. Hayford, A. E. Møller, P. L. Michaelsen et al., Screening of Probioic Aciviies of Forty-Seven Strains of Lactobacillusspp. by In Vitro Techniques and Evaluaion of the Colonizaion Ability of Five Selected Strains in Humans, Appl Environ Microbiol, vol.65, issue.11, pp.4949-4956, 1999.

A. Bezkorovainy, Probioics: determinants of survival and growth in the gut, Am J Clin Nutr, vol.73, issue.2, pp.399-405, 2001.

P. Marteau and F. Shanahan, Basic aspects and pharmacology of probioics: an overview of pharmacokineics, mechanisms of acion and side-efects, Best Pract Res Clin Gastroenterol, vol.17, issue.5, pp.725-765, 2003.

M. Saxelin, T. Pessi, and S. Salminen, Fecal recovery following oral administraion of Lactobacillus strain GG (ATCC 53103) in gelaine capsules to healthy volunteers, Int J Food Microbiol, vol.25, issue.2, pp.199-203, 1995.
DOI : 10.1016/0168-1605(94)00091-j

M. Alander, R. Satokari, R. Korpela, M. Saxelin, T. Vilpponen-salmela et al., Persistence of Colonizaion of Human Colonic Mucosa by a Probioic Strain, Lactobacillus rhamnosus GG, ater Oral Consumpion, Appl Environ Microbiol, 1999.

O. Firmesse, A. Mogenet, J. L. Bresson, G. Corthier, and J. P. Furet, Lactobacillus rhamnosus R11 consumed in a food supplement survived human digesive transit without modifying microbiota equilibrium as assessed by real-ime polymerase chain reacion, J Mol Microbiol Biotechnol, vol.14, issue.1-3, pp.90-99, 2008.
DOI : 10.1159/000106087

S. Spanhaak, R. Havenaar, and G. Schaafsma, The efect of consumpion of milk fermented by Lactobacillus casei strain Shirota on the intesinal microlora and immune parameters in humans, Eur J Clin Nutr, vol.52, issue.12, pp.899-907, 1998.

R. Oozeer, A. Leplingard, D. D. Mater, A. Mogenet, R. Michelin et al., Survival of Lactobacillus casei in the human digesive tract ater consumpion of fermented milk, Appl Environ Microbiol, vol.72, issue.8, pp.5615-5622, 2006.

P. Marteau, P. Pochart, Y. Bouhnik, S. Zidi, I. Goderel et al., Survival of Lactobacillus acidophilus and Biidobacterium sp. in the small intesine following ingesion in fermented milk

, Gastroenterol Clin Biol, vol.16, issue.1, pp.25-33, 1992.

T. Vesa, P. Pochart, and P. Marteau, Pharmacokineics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lacis MG 1363 in the human gastrointesinal tract, Aliment Pharmacol Ther, vol.14, issue.6, pp.823-828, 2000.

T. Shinoda, D. Kusuda, Y. Ishida, N. Ikeda, K. Kaneko et al., Survival of Lactobacillus helveicus strain CP53 in the human gastrointesinal tract, Let Appl Microbiol, vol.32, issue.2, pp.108-113, 2001.

P. Pochart, P. Marteau, Y. Bouhnik, I. Goderel, P. Bourlioux et al., Survival of biidobacteria ingested via fermented milk during their passage through the human small intesine: an in vivo study using intesinal perfusion, Am J Clin Nutr, vol.55, issue.1, pp.78-80, 1992.

Y. Bouhnik, P. Pochart, P. Marteau, G. Arlet, I. Goderel et al., Fecal recovery in humans of viable Biidobacterium sp ingested in fermented milk, Gastroenterology, 1992.

M. J. Kullen, M. M. Amann, O. Shaughnessy, M. J. , O. Sullivan et al., Difereniaion of ingested and endogenous biidobacteria by DNA ingerprining demonstrates the survival of an unmodiied strain in the gastrointesinal tract of humans, J Nutr, vol.127, issue.1, pp.89-94, 1997.

M. Girardin and E. G. Seidman, Indicaions for the use of probioics in gastrointesinal diseases, Dig Dis, vol.29, issue.6, pp.574-87, 2011.

P. Marteau, B. Flourie, P. Pochart, C. Chastang, J. F. Desjeux et al., Efect of the microbial lactase (EC acivity in yoghurt on the intesinal absorpion of lactose: an in vivo study in lactase-deicient humans, Br J Nutr, vol.64, issue.1, pp.71-80, 1990.

A. Anses and . Naionale-de-sécurité-sanitaire, Rapport-Efets des probioiques et prébioiques sur la lore et l'immunité de l'homme adulte, 2005.

H. K. Harms, R. M. Bertele-harms, and D. Bruer-kleis, Enzyme-Subsituion Therapy with the

, Yeast Saccharomyces cerevisiae in Congenital Sucrase-Isomaltase Deiciency, N Engl J Med, vol.316, pp.1306-1309, 1987.

S. Meance, C. Cayuela, P. Turchet, A. Raimondi, C. Lucas et al., A fermented milk with a Biidobacterium probioic Strain DN-173 010 shortened oro-Fecal gut transit ime in elderly, Microb Ecol Health Dis, vol.13, issue.4, pp.217-222, 2001.

M. Tabbers, A. Chmielewska, and M. Roseboom,

M. A. , Efect of the consumpion of a fermented dairy product containing Biidobacterium lacis DN-173 010 on consipaion in childhood: a mulicentre randomised controlled trial (NTRTC: 1571), BMC Pediatr, vol.9, p.22, 2009.

P. Marteau, E. Cuillerier, S. Meance, M. F. Gerhardt, A. Myara et al.,

, Biidobacterium animalis strain DN-173010 shortens the colonic transit ime in healthy women: a double-blind, randomized, controlled study, Aliment Pharmacol Ther, 2002.

A. Agrawal, L. A. Houghton, J. Morris, D. Guyonnet, G. Feuillerat et al., 29-Efets d'un lait fermenté avec le probioique Biidobacterium lacis DN-173 010 sur la distension abdominale, le temps de transit gastrointesinal et les symptômes digesifs chez des sujets ateints du syndrome de l'intesin irritable avec consipaion, Gastroenterol Clin Biol, 2009.

L. E. Miller and A. C. Ouwehand, Probioic supplementaion decreases intesinal transit ime: meta-analysis of randomized controlled trials, World J Gastroenterol, vol.19, issue.29, pp.4718-4743, 2013.

L. E. Miller, A. C. Ouwehand, and A. Ibarra, Efects of probioic-containing products on stool frequency and intesinal transit in consipated adults: systemaic review and meta-analysis of randomized controlled trials, Ann Gastroenterol, vol.30, issue.6, pp.629-639, 2017.

J. Doré, J. Tap, and D. Ehrlich, Techniques d'ideniicaion et d'exploraion du microbiote

P. Marteau and J. Doré, Le microbiote intesinal: un organe à part enière. Montrouge: John libbey eurotext, pp.3-12, 2017.

, INRA science et impact, Insitut Naional de Recherche Agronomique

C. L. Randazzo, A. Pino, L. Ricciardi, C. Romano, D. Comito et al., Probioic supplementaion in systemic nickel allergy syndrome paients: study of its efects on lacic acid bacteria populaion and on clinical symptoms, J Appl Microbiol, vol.118, issue.1, pp.202-213, 2015.

H. Zhang, J. Sun, X. Liu, C. Hong, C. Hong et al.,

, Paracasei LC01 posiively modulates intesinal microlora in healthy young adults, J Microbiol, vol.51, issue.6, pp.777-82, 2013.

F. and F. , Guidelines for the Evaluaion of Probioics in Food Report of a Joint FAO/WHO Working Group on Drating Guidelines for the Evaluaion of Probioics in Food London Ontario, Canada, 2002.

G. Gargari, V. Tavernii, S. Balzarei, C. Ferrario, C. Gardana et al.,

, Consumpion of a Biidobacterium biidum Strain for 4 Weeks Modulates Dominant Intesinal Bacterial Taxa and Fecal Butyrate in Healthy Adults, Appl Environ Microbiol, vol.82, pp.5850-5859, 2016.

A. Pahwa and B. N. Mathur, Assessment of a biidus containing infant formula. Part II. Implantaion of Biidobacterium biidum, Indian J Dairy Sci, vol.40, pp.364-367, 1987.

J. P. Langhendries, J. Detry, J. Van-hees, J. M. Lamboray, J. Darimont et al., Efect of a fermented infant formula containing viable biidobacteria on the fecal lora composiion and pH of healthy full-term infants, J Pediatr Gastroenterol Nutr, vol.21, issue.2, pp.177-81, 1995.

H. Sokol, . Microbiote, and . Efet-de-barrière, microbiote intesinal: un organe à part enière. Montrouge: John libbey eurotext, pp.65-71, 2017.

M. G. El-ziney and J. M. Debevere, The efect of Reuterin on Listeria monocytogenes and Escherichia coli O157:H7 in milk and cotage cheese, J Food Prot, vol.61, issue.10, pp.1275-80, 1998.

C. Marin-gallausiaux, N. Lapaque, and H. Bloière, Microbiote et système immunitaire

P. Marteau and J. Doré, Le microbiote intesinal: un organe à part enière. Montrouge:John libbey eurotext, pp.73-84, 2017.

M. Heyman and E. Heuvelin, Micro-organismes probioiques et régulaion immunologique: le paradoxe. Nutriion Clinique et Métabolisme, vol.20, pp.85-94, 2006.
DOI : 10.1016/j.nupar.2006.04.003

M. Roberfroid, V. Coxam, and N. Delzenne, Aliments foncionnels. 2ème édiion. Tec et Doc Lavoisier, 2007.

L. Pelto, E. Isolauri, E. M. Liluis, J. Nuuila, and S. Salminen, Probioic bacteria down-regulate the milk-induced inlammatory response in milk-hypersensiive subjects but have an immunosimulatory efect in healthy subjects, Clin Exp Allergy, vol.28, pp.1474-79, 1998.
DOI : 10.1046/j.1365-2222.1998.00449.x

K. Arunachalam, H. S. Gill, and R. K. Chandra, Enhancement of natural immune funcion by dietary consumpion of Biidobacterium lacis (HN019), Eur J Clin Nutr, vol.54, issue.3, pp.263-270, 2000.

Y. H. Sheih, B. L. Chiang, L. H. Wang, C. K. Liao, and H. S. Gill, Systemic immunity-enhancing efects in healthy subjects following dietary consumpion of the lacic acid bacterium Lactobacillus rhamnosus HN001, J Am Coll Nutr, issue.2, pp.149-56, 1920.

M. Kaila, E. Isolauri, E. Soppi, E. Virtanen, S. Laine et al.,

H. Link-amster, F. Rochat, K. Y. Saudan, O. Mignot, and J. M. Aeschlimann, Modulaion of a speciic humoral immune response and changes in intesinal lora mediated through fermented milk intake, FEMS Immunol Med Microbiol, vol.10, issue.1, pp.55-63, 1994.

E. Isolauri, J. Joensuu, H. Juomalainen, H. M. Luomala, and T. Vesikari, Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG, Vaccine, vol.13, issue.3, pp.310-312, 1995.

C. Mullié, A. Yazourh, H. Thibault, M. F. Odou, E. Singer et al., Increased poliovirusspeciic intesinal anibody response coincides with promoion of Biidobacterium longuminfanis and Biidobacterium breve in infants: a randomized, double-blind, placebo-controlled trial, Pediatr Res, vol.56, issue.5, pp.791-796, 2004.

M. De-vrese, P. Rautenberg, C. Laue, M. Koopmans, T. Herremans et al., Probioic bacteria simulate virus-speciic neutralizing anibodies following a booster poliovaccinaion

, Eur J Nutr, vol.44, issue.7, pp.406-419, 2005.

A. Bernalier-donadille and P. Pochart, Microbiote intesinal et capacités métaboliques

P. Marteau and J. Doré, Le microbiote intesinal: un organe à part enière. Montrouge:John libbey eurotext, pp.85-93, 2017.

M. L. Jones, C. J. Martoni, and S. Prakash, Oral supplementaion with probioic L. reuteri NCIMB 30242 increases mean circulaing 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial, J Clin Endocrinol Metab, vol.98, issue.7, pp.2944-51, 2013.

G. P. Strozzi and L. Mogna, Quaniicaion of folic acid in human feces ater administraion of Biidobacterium probioic strains, J Clin Gastroenterol, vol.42, issue.3, pp.179-84, 2008.

S. M. Schneider, F. Girard-pipau, J. Filippi, X. Hebuterne, D. Moyse et al., Efects of Saccharomyces boulardii on fecal short-chain faty acids and microlora in paients on long-term total enteral nutriion, World J Gastroenterol, vol.11, issue.39, pp.6165-6174, 2005.

C. Ferrario, V. Tavernii, C. Milani, W. Fiore, M. Laureai et al., Modulaion of fecal Clostridiales bacteria and butyrate by probioic intervenion with Lactobacillus paracasei DG varies among healthy adults, J Nutr, vol.144, issue.11, pp.1787-96, 2014.

T. Pérez-berezo, J. Pujo, P. Marin, L. Faouder, P. Galano et al., Ideniicaion of an analgesic lipopepide produced by the probioic Escherichia coli strain Nissle 1917, Nat Commun, vol.8, issue.1, p.1314, 2017.

S. Newberry, S. Ruelaz, A. Wang, Z. Miles, J. Sutorp et al., Safety of probioics used to reduce risk and prevent or treat disease, Evid Rep Technol Assess (Full Rep, vol.200, pp.1-645, 2011.

T. C. Wallace and D. Mackay, The safety of probioics: consideraions following the 2011 U.S. Agency for Health Research and Quality report, J Nutr, vol.141, issue.11, pp.1923-1927, 2011.

S. Doron and D. R. Snydman, Risk and safety of probioics, Clin Infect Dis, vol.60, 2015.

M. K. Salminen, S. Tynkkynen, H. Rautelin, M. Saxelin, M. Vaara et al., Lactobacillus bacteremia during a rapid increase in probioic use of Lactobacillus rhamnosus GG in Finland

, Clin Infect Dis, vol.35, issue.10, pp.1155-60, 2002.

A. Ouwehand, M. Saxelins, and S. Salminen, Phenotypic Diferences between Commercial Lactobacillus rhamnosus GG and L. Rhamnosus Strains Recovered from Blood, Clin Infect Dis, vol.39, issue.12, pp.1858-1860, 2004.

M. G. Besselink, V. Santvoort, H. C. Buskens, E. Boermeester, M. A. Van-goor et al., Probioic prophylaxis in predicted severe acute pancreaiis: a randomised, doubleblind, placebo-controlled trial, Lancet, vol.371, issue.9613, pp.651-659, 2008.

K. Whelan and C. E. Myers, Safety of probioics in paients receiving nutriional support: a systemaic review of case reports

, Am J Clin Nutr, vol.91, issue.3, pp.687-703, 2010.

M. G. Redman, E. J. Ward, and R. S. Phillips, The eicacy and safety of probioics in people with cancer: a systemaic review, Ann Oncol, vol.25, issue.10, pp.1919-1948, 2014.

M. Olier, I. Marcq, C. Salvador-carier, T. Secher, U. Dobrindt et al., Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probioic acivity. Gut Microbes, vol.3, pp.501-510, 2012.

R. Allem, F. Z. Elkebir, and H. Guetarni, Efet des bactéries laciques sur Helicobacter pylori in vitro. Médecine et nutriion, vol.43, pp.121-127, 2007.

G. Losurdo, R. Cubisino, M. Barone, M. Principi, G. Leandro et al., Probioic monotherapy and Helicobacter pylori eradicaion: A systemaic review with pooled-data analysis, World J Gastroenterol, vol.24, issue.1, pp.139-149, 2018.

S. Hempe, S. J. Newberry, A. R. Maher, Z. Wang, J. N. Miles et al., Probioics for the prevenion and treatment of anibioic-associated diarrhea: a systemaic review and metaanalysis, JAMA, vol.307, issue.18, pp.1959-69, 2009.

C. S. Lau, A. Ward, and R. S. Chamberlain, Probioics improve the eicacy of standard triple therapy in the eradicaion of Helicobacterpylori: a meta-analysis. Infect Drug Resist, vol.9, pp.275-289, 2016.

M. Lü, S. Yu, J. Deng, Q. Yan, C. Yang et al., Eicacy of Probioic Supplementaion Therapy for Helicobacter pylori Eradicaion: A Meta-Analysis of Randomized Controlled Trials, PLoS One, vol.11, issue.10, 2016.

L. V. Mcfarland, Y. Huang, L. Wang, and P. Malfertheiner, Systemaic review and meta-analysis

, Muli-strain probioics as adjunct therapy for Helicobacterpylori eradicaion and prevenion of adverse events, United European Gastroenterol J, vol.4, issue.4, pp.546-61, 2016.

C. Lu, J. Sang, H. He, X. Wan, Y. Lin et al., Probioic supplementaion does not improve eradicaion rate of Helicobacter pylori infecion compared to placebo based on standard therapy: a meta-analysis.Sci Rep, vol.6, p.23522, 2016.

A. Tursi, G. Brandimarte, G. M. Giorgei, and M. E. Modeo, Efect of Lactobacillus casei supplementaion on the efeciveness and tolerability of a new second-line 10-day quadruple therapy ater failure of a irst atempt to cure Helicobacter pylori infecion, Med Sci Monit, vol.10, issue.12, pp.662-668, 2004.

B. S. Sheu, H. C. Cheng, A. W. Kao, S. T. Wang, Y. J. Yang et al., Pretreatment with Lactobacillus-and Biidobacterium-containing yogurt can improve the eicacy of quadruple therapy in eradicaing residual Helicobacter pylori infecion ater failed triple therapy, Am J Clin Nutr, vol.83, issue.4, pp.864-873, 2006.

A. Shavakhi, E. Tabesh, A. Yaghoutkar, H. Hashemi, F. Tabesh et al., The efects of mulistrain probioic compound on bismuth-containing quadruple therapy for Helicobacter pylori infecion: a randomized placebo

, Helicobacter, vol.18, issue.4, pp.280-284, 2013.

C. Srinarong, S. Siramolpiwat, A. Wongcha-um, V. Mahachai, and R. K. Vilaichone, Improved eradicaion rate of standard triple therapy by adding bismuth and probioic supplement for Helicobacter pylori treatment in Thailand, Asian Pac J Cancer Prev, vol.15, issue.22, pp.9909-9922, 2014.

A. Shafaghi, A. Pourkazemi, M. Khosravani, F. Asl, S. et al., The Efect of Probioic Plus Prebioic Supplementaion on the Tolerance and Eicacy of Helicobacter Pylori Eradicaion Quadruple Therapy: a Randomized Prospecive Double Blind Controlled Trial, Middle East J Dig Dis, vol.8, issue.3, pp.179-188, 2016.

C. Schulz, K. Schüte, N. Koch, R. Vilchez-vargas, M. L. Wos-oxley et al., The acive bacterial assemblages of the upper GI tract in individuals with and without Helicobacter infecion, Gut, vol.67, issue.2, pp.216-225, 2018.

J. Tong, Z. H. Ran, J. Shen, C. X. Zhang, and S. D. Xiao, Meta-analysis: the efect of supplementaion with probioics on eradicaion rates and adverse events during Helicobacter pylori eradicaion therapy, Aliment Pharmacol Ther, vol.25, issue.2, pp.155-68, 2007.

J. Zou, J. Dong, and X. Yu, Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple irst-line therapy for Helicobacter pylori eradicaion, Helicobacter, 2009.

H. Szajewska, A. Horvath, and A. Piwowarczyk, Meta-analysis: the efects of Saccharomyces boulardii supplementaion on Helicobacter pylori eradicaion rates and side efects during treatment, Aliment Pharmacol Ther, vol.32, issue.9, pp.1069-79, 2010.

Z. H. Wang, Q. Y. Gao, and J. Y. Fang, Meta-analysis of the eicacy and safety of Lactobacilluscontaining and Biidobacterium-containing probioic compound preparaion in Helicobacter pylori eradicaion therapy, J Clin Gastroenterol, vol.47, issue.1, pp.25-32, 2013.

X. Zheng, L. Lyu, and Z. Mei, Lactobacillus-containing probioic supplementaion increases

, Helicobacter pylori eradicaion rate: evidence from a meta-analysis, Rev Esp Enferm Dig, vol.105, issue.8, pp.445-53, 2013.

Y. Dang, J. D. Reinhardt, X. Zhou, and G. Zhang, The efect of probioics supplementaion on Helicobacter pylori eradicaion rates and side efects during eradicaion therapy: a metaanalysis, PLoS One, vol.3, issue.11, 2014.

R. Zhu, K. Chen, Y. Y. Zheng, H. W. Zhang, J. S. Wang et al., Meta-analysis of the eicacy of probioics in Helicobacter pylori eradicaion therapy, World J Gastroenterol, vol.20, issue.47, pp.18013-18034, 2014.

Z. Lv, B. Wang, X. Zhou, F. Wang, Y. Xie et al., Eicacy and safety of probioics as adjuvant agents for Helicobacter pylori infecion: A meta-analysis, Exp Ther Med, 2015.

M. M. Zhang, W. Qian, Y. Y. Qin, J. He, and Y. Zhou, Probioics in Helicobacter pylori eradicaion therapy: a systemaic review and meta-analysis, World J Gastroenterol, vol.21, issue.14, pp.4345-57, 2015.

F. Wang, J. Feng, P. Chen, X. Liu, M. Ma et al., Probioics in Helicobacter pylori eradicaion therapy: Systemaic review and network meta-analysis, Clin Res Hepatol Gastroenterol, vol.41, issue.4, pp.466-475, 2017.

N. Valeur, P. Engel, N. Carbajal, E. Connolly, and K. Ladefoged, Colonizaion and immunomodulaion by Lactobacillus reuteri ATCC 55730 in the human gastrointesinal tract

, Appl Environ Microbiol, vol.70, issue.2, pp.1176-81, 2004.

T. Piche, Diarrhée associée aux anibioiques. Hépato-gastro et oncologie digesive, 2002.

J. A. Madden, S. F. Plummer, J. Tang, I. Garaiova, N. T. Plummer et al., Efect of probioics on prevening disrupion of the intesinal microlora following anibioic therapy: a double-blind, placebo-controlled pilot study, Int Immunopharmacol, vol.5, issue.6, pp.1091-1098, 2005.

E. Myllyluoma, T. Ahlroos, L. Veijola, H. Rautelin, S. Tynkkynen et al., Efects of aniHelicobacter pylori treatment and probioic supplementaion on intesinal microbiota, Int J Animicrob Agents, vol.29, issue.1, pp.66-72, 2007.

B. Oh, B. S. Kim, J. W. Kim, J. S. Kim, S. J. Koh et al., The Efect of Probioics on Gut Microbiota during the Helicobacter pylori Eradicaion

. Helicobacter, , vol.21, pp.165-74, 2016.

J. Goldbergen, C. Yap, L. Lytvyn, C. Lo, J. Beardsley et al., Probioics for the prevenion of Clostridium diicile-associated diarrhea in adults and children. Cochrane Database of Systemaic Review, vol.12, 2017.